Late season interim estimates of influenza vaccine effectiveness reliably predict end of season estimates in Victoria, Australia, 2007 to 2012
Open Access
- 10 October 2013
- journal article
- research article
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 18 (41) , 20605-11
- https://doi.org/10.2807/1560-7917.es2013.18.41.20605
Abstract
Twice each year the World Health Organization makes a recommendation for the composition of the influenza vaccine, based on circulating strains of influenza A(H3N2), A(H1N1) and B. Strain selection has always been based on immunogenicity studies with limited human data. Immunogenicity can be considered as a proxy for vaccine effectiveness (VE). However, only interim VE estimates for the target hemisphere can be considered in time for the strain selection meeting. Using surveillance data from Victoria, Australia, we retrospectively estimated and compared interim and final VE estimates for 2007 to 2012. In general, interim estimates were within five percentage points of final estimates. However, estimates made too early or in years of low influenza activity may be unreliable.This publication has 28 references indexed in Scilit:
- The case test-negative design for studies of the effectiveness of influenza vaccineVaccine, 2013
- The test-negative design for estimating influenza vaccine effectivenessVaccine, 2013
- I-MOVE Multi-Centre Case Control Study 2010-11: Overall and Stratified Estimates of Influenza Vaccine Effectiveness in EuropePLOS ONE, 2011
- Influenza vaccine effectiveness in Wisconsin during the 2007–08 season: Comparison of interim and final resultsVaccine, 2011
- Effectiveness of Seasonal Influenza Vaccine against Pandemic (H1N1) 2009 Virus, Australia, 2010Emerging Infectious Diseases, 2011
- Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008BMC Infectious Diseases, 2011
- Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: Basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009–2010 Northern Hemisphere seasonVaccine, 2010
- Estimation of Influenza Vaccine Effectiveness from Routine Surveillance DataPLOS ONE, 2009
- Component‐Specific Effectiveness of Trivalent Influenza Vaccine as Monitored through a Sentinel Surveillance Network in Canada, 2006–2007The Journal of Infectious Diseases, 2009
- A solution to the problem of separation in logistic regressionStatistics in Medicine, 2002